Status:
NOT_YET_RECRUITING
Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer Enterostomy
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to understand the application effect of the applicable version of Baduanjin protocol in patients with enterostomy and verify the safety and efficacy of this protocol...
Eligibility Criteria
Inclusion
- The disease diagnosis is colorectal cancer
- At present, enterostomy is used for excretion, and the enterostomy time is more than one month
- Age ≥ 18 years old
- Have normal cognitive and expression abilities
- Voluntarily participate in this study and have signed the informed consent form.
Exclusion
- In the past three months, I have participated in any intervention research or traditional Chinese medical exercise training programs (such as Tai Chi, Baduanjin, other Qigong exercises, etc.)
- Patients with severe functional disorders of the heart, lungs, liver, kidneys and other organs
- Mental abnormalities and language expression disorders
- Patients with limb dysfunction who are unable to cooperate in completing the Baduanjin training
- Various drainage tubes, PICC catheters, etc. were retained -
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
258 Patients enrolled
Trial Details
Trial ID
NCT07172087
Start Date
September 1 2025
End Date
December 1 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Afffliated Cancer Hospital of University of Electronic Science and Technology of China
Chengdu, Sichuan, China, 610041